These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6310691

  • 21. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K, Dziubina A.
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [Abstract] [Full Text] [Related]

  • 22. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
    de Belleroche J, Gardiner IM.
    J Neural Transm; 1983 Sep; 58(3-4):153-68. PubMed ID: 6141217
    [Abstract] [Full Text] [Related]

  • 23. Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
    Serra PA, Esposito G, Enrico P, Mura MA, Migheli R, Delogu MR, Miele M, Desole MS, Grella G, Miele E.
    Br J Pharmacol; 2000 Jun; 130(4):937-45. PubMed ID: 10864903
    [Abstract] [Full Text] [Related]

  • 24. Effect of mild postnatal hypoxia and L-dopa administration on dopamine concentration in striata of the newborn rat and long term sequelae on dopamine turnover.
    Lun A, Szuecz L, Gross J, Horvath G, Nagy I.
    Biomed Biochim Acta; 1989 Jun; 48(2-3):S231-6. PubMed ID: 2730615
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.
    Dluzen DE, Liu B.
    J Neural Transm Gen Sect; 1994 Jun; 95(3):209-22. PubMed ID: 7865176
    [Abstract] [Full Text] [Related]

  • 27. Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
    Adachi K, Miwa H, Kusumoto H, Shimazu S, Kondo T.
    J Pharmacol Sci; 2006 Aug; 101(4):286-92. PubMed ID: 16891770
    [Abstract] [Full Text] [Related]

  • 28. Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants.
    Holcomb HH, Bannon MJ, Roth RH.
    Eur J Pharmacol; 1982 Aug 27; 82(3-4):173-8. PubMed ID: 6813129
    [Abstract] [Full Text] [Related]

  • 29. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Aug 27; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

  • 30. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
    Tyce GM, Rorie DK.
    Life Sci; 1985 Dec 23; 37(25):2439-48. PubMed ID: 4079658
    [Abstract] [Full Text] [Related]

  • 31. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 23; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 32. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 23; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 33. Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.
    Melamed E, Hefti F, Bitton V, Globus M.
    Neurology; 1984 Dec 23; 34(12):1566-70. PubMed ID: 6504328
    [Abstract] [Full Text] [Related]

  • 34. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A, Ceresoli G, Mandelli V, Parenti M.
    J Pharmacol Exp Ther; 1990 Jun 23; 253(3):950-6. PubMed ID: 2162953
    [Abstract] [Full Text] [Related]

  • 35. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 36. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats.
    Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M.
    Neuroreport; 1999 Feb 25; 10(3):631-4. PubMed ID: 10208602
    [Abstract] [Full Text] [Related]

  • 37. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 38. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D, Karain B, Brantley E, Shi WX.
    J Pharmacol Exp Ther; 2011 May 28; 337(2):533-9. PubMed ID: 21330359
    [Abstract] [Full Text] [Related]

  • 39. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.
    Meller E, Helmer-Matyjek E, Bohmaker K, Adler CH, Friedhoff AJ, Goldstein M.
    Eur J Pharmacol; 1986 Apr 16; 123(2):311-4. PubMed ID: 3709668
    [Abstract] [Full Text] [Related]

  • 40. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
    Gołembiowska K, Dziubina A, Kowalska M, Kamińska K.
    Pharmacol Rep; 2008 Apr 16; 60(3):319-30. PubMed ID: 18622056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.